VALUES OF THE IMMUNE ACTIVATION MARKERS CD38 AND HLA-DR AND THE RATIO CD4/CD8 ACCORDING TO THE DELAY OF COMBINED ANTIRETROVIRAL THERAPY (C-ART) INITIATION IN PRIMARY HIV-INFECTED PATIENTS (PRIMIMMUNO):